StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 01/14/2014 -- StockRunway.com issues special report on - Elite Pharmaceuticals Inc(OTCBB:ELTP), Nestle SA Reg Shs. Ser. B Spons (ADR)(OTCMKTS:NSRGY), Axxess Pharma Inc(OTCMKTS:AXXE), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT)
Elite Pharmaceuticals Inc(OTCBB:ELTP) increased 7.95% at the price of $0.189 recently on a traded volume of 7.41million shares, in comparison to 2.00 million shares of average trading volume. So far this year, the stock is up over 57.25%.
The company has a total market capitalization of $95.85 million and its total outstanding shares are 507.94 million. Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets
For How Long ELTP will Fight for Profitability? Read This Trend Analysis report
Nestle SA Reg Shs. Ser. B Spons (ADR)(OTCMKTS:NSRGY) soared 0.07% at the trading price of $73.62 on a traded volume of 217,006.00 shares till now, whereas its average trading volume is 607,317.00 shares. In the last three months, the stock is up 8.15%. The Intra-day range for the stock is $73.47 and $73.80. Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage. The Group manages its Food and Beverages business through three geographic zones (Zone Europe, Zone Americas and Zone Asia, Oceania and Africa) and globally for Nestle Waters, Nestle Nutrition and Other Food and Beverages (Others).
For How Long NSRGY Gloss will Attract Investors? Find out via this report
Axxess Pharma Inc(OTCMKTS:AXXE) jumped up 8.61% at the $0.290 recently. So far in three months, the stock is down -1.69%. The 52-week range for the stock is $0.14 and $1.04. Its introductory price for the day was $0.30, with the overall traded volume of 1.87 million shares. Axxess Pharma Inc. is a pharmaceutical company. It is engaged in marketing of dermatological, therapeutic nutritionals, pain management, and diagnostic products in Canada and abroad. In October 2013, the Company announced that it has incorporated a wholly owned subsidiary AllStar HealthBrands Inc.
Will AXXE Continue To Move Higher? Find Out Here
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), after opening its shares at the price of $2.74 , its recent trading price was $2.69 for the day. The stock moved on a traded volume of 747,888.00 shares, in comparison to 2.00 million shares of average trading volume.
The 52-week range for the stock is $0.55 and $3.00. Its introductory price for the day was $2.74. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
What PVCT Charts Are Signaling for Traders? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)